Atonement
The fallout from Daniel Carlat’s piece in the New York Times continues. Ed Silverman over at Pharmalot landed an interview with Carlat where he addresses the calls for him to return the $30,000 he got from Wyeth. As for whether he expected the kind of response that has followed the piece, Carlat said:
Actually, I expected some of it. I’m surprised more by the amount of comments I’ve gotten. A lot of it has been good. If you go to my site, you’ll see a lot of comments that are mostly congratulations for acknowledging what I did. A few wrote that I’m a hypocrite who passed myself off as an ethical person but then took money to go from function to function to talk about a drug that gave me pause.
John Mack, over at Pharma Marketing Blog, gives his take.
So, should Carlat return the money? Donate it to charity? Or is the simple act of writing the essay in the first place sufficient?
